These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19072486)

  • 21. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women's health. The role of gender in HIV progression.
    Hewitt RG; Parsa N; Gugino L
    AIDS Read; 2001 Jan; 11(1):29-33. PubMed ID: 11215085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
    Kesselring AM; Wit FW; Sabin CA; Lundgren JD; Gill MJ; Gatell JM; Rauch A; Montaner JS; de Wolf F; Reiss P; Mocroft A;
    AIDS; 2009 Aug; 23(13):1689-99. PubMed ID: 19487907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral treatment in pregnancy.
    Anderson JR
    Hopkins HIV Rep; 1998 May; 10(3):6-7, 10. PubMed ID: 11365495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of fosamprenavir in human immunodeficiency virus-infected pregnant women.
    Martorell C; Theroux E; Bermudez A; Garb J; Kronschnabel D; Oie K
    Pediatr Infect Dis J; 2010 Oct; 29(10):985. PubMed ID: 20859183
    [No Abstract]   [Full Text] [Related]  

  • 32. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
    Galluzzo C; Liotta G; Andreotti M; Luhanga R; Jere H; Mancinelli S; Maulidi M; Sagno JB; Pirillo M; Erba F; Amici R; Ceffa S; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Med Virol; 2012 Oct; 84(10):1553-7. PubMed ID: 22930502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Revised guideline "Antiretroviral Treatment"].
    Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-positive women in Australia explain their use and non-use of antiretroviral therapy in preventing mother-to-child transmission.
    McDonald K; Kirkman M
    AIDS Care; 2011 May; 23(5):578-84. PubMed ID: 20824555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
    Darak S; Darak T; Kulkarni S; Kulkarni V; Parchure R; Hutter I; Janssen F
    AIDS Patient Care STDS; 2013 Mar; 27(3):163-70. PubMed ID: 23477457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral-naïve patients.
    Hart E; Curtis H; Wilkins E; Johnson M
    HIV Med; 2007 Apr; 8(3):186-91. PubMed ID: 17461863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical treatment of women and adherence to HIV guidelines at an urban university-staffed public clinic.
    Parikh MJ; Cheng L; Nieman LZ; Grimes RM
    J Womens Health (Larchmt); 2003 Nov; 12(9):897-902. PubMed ID: 14670169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From PMTCT to a more comprehensive AIDS response for women: a much-needed shift.
    Eyakuze C; Jones DA; Starrs AM; Sorkin N
    Dev World Bioeth; 2008 Apr; 8(1):33-42. PubMed ID: 18315723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa.
    Myer L; Zulliger R; Black S; Pienaar D; Bekker LG
    AIDS Care; 2012; 24(8):986-92. PubMed ID: 22519561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.